annual EBITDA:
$177.44M+$48.70M(+37.83%)Summary
- As of today (May 24, 2025), AMED annual EBITDA is $177.44 million, with the most recent change of +$48.70 million (+37.83%) on December 31, 2024.
- During the last 3 years, AMED annual EBITDA has fallen by -$183.58 million (-50.85%).
- AMED annual EBITDA is now -50.85% below its all-time high of $361.02 million, reached on December 31, 2021.
Performance
AMED EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$113.06M+$109.90M(+3477.82%)Summary
- As of today (May 24, 2025), AMED quarterly EBITDA is $113.06 million, with the most recent change of +$109.90 million (+3477.82%) on March 31, 2025.
- Over the past year, AMED quarterly EBITDA has increased by +$63.01 million (+125.89%).
- AMED quarterly EBITDA is now -11.44% below its all-time high of $127.67 million, reached on June 30, 2021.
Performance
AMED quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$240.45M+$63.01M(+35.51%)Summary
- As of today (May 24, 2025), AMED TTM EBITDA is $240.45 million, with the most recent change of +$63.01 million (+35.51%) on March 31, 2025.
- Over the past year, AMED TTM EBITDA has increased by +$118.20 million (+96.69%).
- AMED TTM EBITDA is now -37.12% below its all-time high of $382.37 million, reached on June 30, 2021.
Performance
AMED TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMED EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.8% | +125.9% | +96.7% |
| 3 y3 years | -50.9% | +73.9% | -28.9% |
| 5 y5 years | -25.8% | +91.6% | -0.3% |
AMED EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.9% | +37.8% | at high | +381.4% | -28.9% | +96.7% |
| 5 y | 5-year | -50.9% | +37.8% | -11.4% | +381.4% | -37.1% | +96.7% |
| alltime | all time | -50.9% | +141.4% | -11.4% | +120.8% | -37.1% | +151.2% |
AMED EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $113.06M(+3477.8%) | $240.45M(+35.5%) |
| Dec 2024 | $177.44M(+37.8%) | $3.16M(-93.9%) | $177.44M(-21.5%) |
| Sep 2024 | - | $52.21M(-27.5%) | $226.17M(-3.5%) |
| Jun 2024 | - | $72.02M(+43.9%) | $234.45M(+91.8%) |
| Mar 2024 | - | $50.05M(-3.5%) | $122.25M(-5.0%) |
| Dec 2023 | $128.74M(-49.2%) | $51.89M(-14.2%) | $128.74M(-8.3%) |
| Sep 2023 | - | $60.49M(-250.5%) | $140.44M(+2.1%) |
| Jun 2023 | - | -$40.18M(-171.1%) | $137.53M(-43.9%) |
| Mar 2023 | - | $56.54M(-11.1%) | $244.97M(-3.3%) |
| Dec 2022 | $253.44M(-29.8%) | $63.59M(+10.4%) | $253.44M(-2.1%) |
| Sep 2022 | - | $57.58M(-14.4%) | $258.84M(-6.9%) |
| Jun 2022 | - | $67.25M(+3.5%) | $277.93M(-17.9%) |
| Mar 2022 | - | $65.01M(-5.8%) | $338.35M(-6.3%) |
| Dec 2021 | $361.02M(+24.6%) | $69.00M(-10.0%) | $361.02M(-3.8%) |
| Sep 2021 | - | $76.67M(-39.9%) | $375.27M(-1.9%) |
| Jun 2021 | - | $127.67M(+45.6%) | $382.37M(+20.1%) |
| Mar 2021 | - | $87.68M(+5.3%) | $318.46M(+9.9%) |
| Dec 2020 | $289.80M(+21.1%) | $83.24M(-0.6%) | $289.80M(+9.8%) |
| Sep 2020 | - | $83.78M(+31.4%) | $263.86M(+9.0%) |
| Jun 2020 | - | $63.76M(+8.0%) | $241.99M(+0.3%) |
| Mar 2020 | - | $59.02M(+3.0%) | $241.24M(+0.8%) |
| Dec 2019 | $239.26M(+33.2%) | $57.30M(-7.4%) | $239.26M(+7.1%) |
| Sep 2019 | - | $61.91M(-1.7%) | $223.47M(+7.4%) |
| Jun 2019 | - | $63.01M(+10.5%) | $208.09M(+7.0%) |
| Mar 2019 | - | $57.04M(+37.4%) | $194.48M(+8.3%) |
| Dec 2018 | $179.62M(+74.5%) | $41.51M(-10.8%) | $179.62M(+4.1%) |
| Sep 2018 | - | $46.53M(-5.8%) | $172.61M(+10.9%) |
| Jun 2018 | - | $49.40M(+17.1%) | $155.63M(+35.9%) |
| Mar 2018 | - | $42.18M(+22.2%) | $114.53M(+11.2%) |
| Dec 2017 | $102.95M(+19.1%) | $34.50M(+16.8%) | $102.95M(+14.8%) |
| Sep 2017 | - | $29.55M(+256.0%) | $89.67M(+5.9%) |
| Jun 2017 | - | $8.30M(-72.9%) | $84.66M(-15.9%) |
| Mar 2017 | - | $30.61M(+44.3%) | $100.73M(+16.6%) |
| Dec 2016 | $86.41M(+183.2%) | $21.21M(-13.6%) | $86.41M(-7.2%) |
| Sep 2016 | - | $24.54M(+0.7%) | $93.07M(-0.1%) |
| Jun 2016 | - | $24.36M(+49.6%) | $93.15M(-1.2%) |
| Mar 2016 | - | $16.29M(-41.6%) | $94.26M(+208.9%) |
| Dec 2015 | $30.51M(-47.0%) | $27.88M(+13.2%) | $30.51M(+17.5%) |
| Sep 2015 | - | $24.62M(-3.3%) | $25.96M(+4.7%) |
| Jun 2015 | - | $25.47M(-153.7%) | $24.80M(+19.6%) |
| Mar 2015 | - | -$47.46M(-303.4%) | $20.73M(-64.0%) |
| Dec 2014 | $57.54M(-151.5%) | $23.33M(-0.5%) | $57.54M(+84.2%) |
| Sep 2014 | - | $23.46M(+9.6%) | $31.24M(-123.9%) |
| Jun 2014 | - | $21.40M(-300.9%) | -$130.47M(-5.6%) |
| Mar 2014 | - | -$10.65M(+258.7%) | -$138.26M(+23.8%) |
| Dec 2013 | -$111.68M(+77.0%) | -$2.97M(-97.9%) | -$111.68M(-55.0%) |
| Sep 2013 | - | -$138.25M(-1115.3%) | -$248.10M(+194.9%) |
| Jun 2013 | - | $13.62M(-14.5%) | -$84.12M(+16.5%) |
| Mar 2013 | - | $15.92M(-111.4%) | -$72.18M(+11.5%) |
| Dec 2012 | -$63.10M(-85.3%) | -$139.39M(-641.8%) | -$64.73M(-163.9%) |
| Sep 2012 | - | $25.73M(+0.6%) | $101.26M(-121.6%) |
| Jun 2012 | - | $25.56M(+9.4%) | -$469.36M(+5.5%) |
| Mar 2012 | - | $23.37M(-12.1%) | -$444.95M(+3.8%) |
| Dec 2011 | -$428.70M(-273.5%) | $26.60M(-104.9%) | -$428.70M(+10.0%) |
| Sep 2011 | - | -$544.89M(-1190.5%) | -$389.76M(-293.0%) |
| Jun 2011 | - | $49.97M(+26.1%) | $201.98M(-6.3%) |
| Mar 2011 | - | $39.62M(-39.5%) | $215.68M(-12.7%) |
| Dec 2010 | $247.03M(-5.9%) | $65.53M(+39.9%) | $247.03M(-2.4%) |
| Sep 2010 | - | $46.86M(-26.4%) | $253.13M(-8.1%) |
| Jun 2010 | - | $63.66M(-10.3%) | $275.50M(-1.4%) |
| Mar 2010 | - | $70.97M(-0.9%) | $279.29M(+6.4%) |
| Dec 2009 | $262.38M | $71.64M(+3.5%) | $262.38M(+7.9%) |
| Sep 2009 | - | $69.22M(+2.6%) | $243.17M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | $67.45M(+24.8%) | $223.47M(+11.4%) |
| Mar 2009 | - | $54.06M(+3.1%) | $200.60M(+11.9%) |
| Dec 2008 | $178.39M(+51.2%) | $52.43M(+5.9%) | $179.30M(+8.8%) |
| Sep 2008 | - | $49.52M(+11.1%) | $164.78M(+13.8%) |
| Jun 2008 | - | $44.59M(+36.1%) | $144.85M(+13.8%) |
| Mar 2008 | - | $32.76M(-13.6%) | $127.33M(+7.9%) |
| Dec 2007 | $118.00M(+54.8%) | $37.91M(+28.1%) | $118.00M(+15.6%) |
| Sep 2007 | - | $29.59M(+9.3%) | $102.03M(+9.5%) |
| Jun 2007 | - | $27.07M(+15.5%) | $93.22M(+10.2%) |
| Mar 2007 | - | $23.43M(+6.8%) | $84.55M(+10.9%) |
| Dec 2006 | $76.21M(+33.5%) | $21.94M(+5.6%) | $76.21M(+11.9%) |
| Sep 2006 | - | $20.77M(+12.8%) | $68.10M(+7.3%) |
| Jun 2006 | - | $18.41M(+22.0%) | $63.48M(+7.0%) |
| Mar 2006 | - | $15.09M(+9.1%) | $59.32M(+3.9%) |
| Dec 2005 | $57.08M(+52.2%) | $13.83M(-14.4%) | $57.08M(+5.1%) |
| Sep 2005 | - | $16.15M(+13.3%) | $54.29M(+13.6%) |
| Jun 2005 | - | $14.25M(+10.9%) | $47.81M(+12.4%) |
| Mar 2005 | - | $12.85M(+16.3%) | $42.55M(+13.5%) |
| Dec 2004 | $37.50M(+115.4%) | $11.04M(+14.2%) | $37.50M(+13.8%) |
| Sep 2004 | - | $9.67M(+7.5%) | $32.96M(+17.9%) |
| Jun 2004 | - | $8.99M(+15.3%) | $27.96M(+25.5%) |
| Mar 2004 | - | $7.80M(+19.9%) | $22.29M(+28.0%) |
| Dec 2003 | $17.41M(+57.3%) | $6.50M(+39.3%) | $17.41M(+53.2%) |
| Sep 2003 | - | $4.67M(+40.6%) | $11.37M(+16.0%) |
| Jun 2003 | - | $3.32M(+13.5%) | $9.80M(-4.2%) |
| Mar 2003 | - | $2.92M(+539.8%) | $10.22M(-7.6%) |
| Dec 2002 | $11.07M(+1.5%) | $457.00K(-85.3%) | $11.07M(-25.2%) |
| Sep 2002 | - | $3.10M(-17.2%) | $14.80M(-1.9%) |
| Jun 2002 | - | $3.75M(-0.6%) | $15.08M(+8.7%) |
| Mar 2002 | - | $3.77M(-10.1%) | $13.87M(-1.0%) |
| Dec 2001 | $10.90M(+3439.6%) | $4.19M(+24.0%) | $14.00M(+33.1%) |
| Sep 2001 | - | $3.38M(+33.4%) | $10.52M(+52.2%) |
| Jun 2001 | - | $2.53M(-35.1%) | $6.91M(+57.6%) |
| Mar 2001 | - | $3.90M(+455.2%) | $4.38M(+1323.7%) |
| Dec 2000 | $308.00K(-30.5%) | $703.00K(-409.7%) | $308.00K(-178.0%) |
| Sep 2000 | - | -$227.00K(-3883.3%) | -$395.00K(+135.1%) |
| Jun 2000 | - | $6000.00(-103.4%) | -$168.00K(-3.4%) |
| Mar 2000 | - | -$174.00K(-52.3%) | -$174.00K(-98.3%) |
| Dec 1999 | $443.00K(-101.9%) | - | - |
| Mar 1999 | - | -$365.00K(-81.8%) | -$10.47M(-21.9%) |
| Dec 1998 | -$23.91M(-3766.6%) | -$2.01M(-66.0%) | -$13.41M(+48.2%) |
| Sep 1998 | - | -$5.90M(+168.2%) | -$9.05M(+196.9%) |
| Jun 1998 | - | -$2.20M(-33.3%) | -$3.05M(-2105.3%) |
| Mar 1998 | - | -$3.30M(-240.3%) | $152.00K(-96.5%) |
| Dec 1997 | $652.00K(-68.8%) | $2.35M(+2252.0%) | $4.35M(+18.0%) |
| Sep 1997 | - | $100.00K(-90.0%) | $3.69M(-9.8%) |
| Jun 1997 | - | $1.00M(+11.1%) | $4.09M(+7.9%) |
| Mar 1997 | - | $900.00K(-46.7%) | $3.79M(+8.6%) |
| Dec 1996 | $2.09M(+4.4%) | $1.69M(+237.7%) | $3.49M(+51.7%) |
| Sep 1996 | - | $500.00K(-28.6%) | $2.30M(+4.5%) |
| Jun 1996 | - | $700.00K(+16.7%) | $2.20M(+10.0%) |
| Mar 1996 | - | $600.00K(+20.0%) | $2.00M(+17.6%) |
| Dec 1995 | $2.00M(+300.0%) | $500.00K(+25.0%) | $1.70M(-110.2%) |
| Sep 1995 | - | $400.00K(-20.0%) | -$16.60M(+58.1%) |
| Jun 1995 | - | $500.00K(+66.7%) | -$10.50M(-3.7%) |
| Mar 1995 | - | $300.00K(-101.7%) | -$10.90M(-1.8%) |
| Dec 1994 | $500.00K(+400.0%) | -$17.80M(-373.8%) | -$11.10M(+122.0%) |
| Sep 1994 | - | $6.50M(+6400.0%) | -$5.00M(-45.7%) |
| Jun 1994 | - | $100.00K(0.0%) | -$9.20M(+100.0%) |
| Mar 1994 | - | $100.00K(-100.9%) | -$4.60M(+4500.0%) |
| Dec 1993 | $100.00K | -$11.70M(-608.7%) | -$100.00K(-100.9%) |
| Sep 1993 | - | $2.30M(-51.1%) | $11.60M(+24.7%) |
| Jun 1993 | - | $4.70M(+2.2%) | $9.30M(+102.2%) |
| Mar 1993 | - | $4.60M | $4.60M |
FAQ
- What is Amedisys annual EBITDA?
- What is the all time high annual EBITDA for Amedisys?
- What is Amedisys annual EBITDA year-on-year change?
- What is Amedisys quarterly EBITDA?
- What is the all time high quarterly EBITDA for Amedisys?
- What is Amedisys quarterly EBITDA year-on-year change?
- What is Amedisys TTM EBITDA?
- What is the all time high TTM EBITDA for Amedisys?
- What is Amedisys TTM EBITDA year-on-year change?
What is Amedisys annual EBITDA?
The current annual EBITDA of AMED is $177.44M
What is the all time high annual EBITDA for Amedisys?
Amedisys all-time high annual EBITDA is $361.02M
What is Amedisys annual EBITDA year-on-year change?
Over the past year, AMED annual EBITDA has changed by +$48.70M (+37.83%)
What is Amedisys quarterly EBITDA?
The current quarterly EBITDA of AMED is $113.06M
What is the all time high quarterly EBITDA for Amedisys?
Amedisys all-time high quarterly EBITDA is $127.67M
What is Amedisys quarterly EBITDA year-on-year change?
Over the past year, AMED quarterly EBITDA has changed by +$63.01M (+125.89%)
What is Amedisys TTM EBITDA?
The current TTM EBITDA of AMED is $240.45M
What is the all time high TTM EBITDA for Amedisys?
Amedisys all-time high TTM EBITDA is $382.37M
What is Amedisys TTM EBITDA year-on-year change?
Over the past year, AMED TTM EBITDA has changed by +$118.20M (+96.69%)